| Dr Aaron Benjamin Domm, MD | |
|
5500 Front St # 260, Summerville, SC 29486-7735 | |
| (843) 376-0670 | |
| (843) 376-0669 |
| Full Name | Dr Aaron Benjamin Domm |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 5500 Front St # 260, Summerville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760527576 | NPI | - | NPPES |
| P01058405 | Other | SC | RR MEDICARE |
| 297486 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 29748 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trident Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ppcp Specialty Physicians , Llc | 2466723028 | 18 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
Biologists at Purdue University have determined the combined structure of a common-cold virus attached to a molecule that enables the virus to infect its host, information that ultimately may help researchers develop methods for treating certain viral infections.
Like much of the rest of the body, the brain loses flexibility with age, impacting the ability to learn, remember, and adapt. Now, scientists at University of Utah Health report they can rejuvenate the plasticity of the mouse brain, specifically in the visual cortex, increasing its ability to change in response to experience.
› Verified 5 days ago
| Entity Name | Palmetto Primary Care Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073234928 PECOS PAC ID: 4880508068 Enrollment ID: O20031113000287 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
Biologists at Purdue University have determined the combined structure of a common-cold virus attached to a molecule that enables the virus to infect its host, information that ultimately may help researchers develop methods for treating certain viral infections.
Like much of the rest of the body, the brain loses flexibility with age, impacting the ability to learn, remember, and adapt. Now, scientists at University of Utah Health report they can rejuvenate the plasticity of the mouse brain, specifically in the visual cortex, increasing its ability to change in response to experience.
› Verified 5 days ago
| Entity Name | Ppcp Specialty Physicians , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780123984 PECOS PAC ID: 2466723028 Enrollment ID: O20170801001865 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
Biologists at Purdue University have determined the combined structure of a common-cold virus attached to a molecule that enables the virus to infect its host, information that ultimately may help researchers develop methods for treating certain viral infections.
Like much of the rest of the body, the brain loses flexibility with age, impacting the ability to learn, remember, and adapt. Now, scientists at University of Utah Health report they can rejuvenate the plasticity of the mouse brain, specifically in the visual cortex, increasing its ability to change in response to experience.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Benjamin Domm, MD Po Box 530062, Atlanta, GA 30353-0062 Ph: (843) 695-6071 | Dr Aaron Benjamin Domm, MD 5500 Front St # 260, Summerville, SC 29486-7735 Ph: (843) 376-0670 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
Biologists at Purdue University have determined the combined structure of a common-cold virus attached to a molecule that enables the virus to infect its host, information that ultimately may help researchers develop methods for treating certain viral infections.
Like much of the rest of the body, the brain loses flexibility with age, impacting the ability to learn, remember, and adapt. Now, scientists at University of Utah Health report they can rejuvenate the plasticity of the mouse brain, specifically in the visual cortex, increasing its ability to change in response to experience.
› Verified 5 days ago
Dr. Orlin Sergev, M.D., PH.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 622 Old Trolley Rd, Suite 102, Summerville, SC 29485 Phone: 843-871-7979 Fax: 843-871-8282 | |
Jeffrey R Herman, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1516 Old Trolley Rd Ste 101, Summerville, SC 29485 Phone: 843-203-9393 | |
Juan Carlos Camacho Velazquez, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Callen Blvd, Summerville, SC 29486 Phone: 843-529-3100 | |
Benoit Lebrun, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 295 Midland Pkwy, Summerville, SC 29485 Phone: 713-591-9963 | |
Dr. Nicholas Holdgate, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2001 2nd Ave Ste 201, Summerville, SC 29486 Phone: 843-572-4840 Fax: 843-764-2726 | |
David Eric Bolster, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1516 Old Trolley Rd # 101, Summerville, SC 29485 Phone: 843-203-9393 Fax: 843-492-4673 | |
Dr. Colin Clark Edgerton, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2001 2nd Ave Ste 201, Summerville, SC 29486 Phone: 843-572-4840 Fax: 843-793-6156 |